Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target […]
Arcus Biosciences, Inc. Forecasted to Post Q2 2024 Earnings of ($0.88) Per Share (NYSE:RCUS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Brokers Set Expectations for Arcus Biosciences, Inc.'s Q1 2025 Earnings (NYSE:RCUS) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Equities Analysts Offer Predictions for Arcus Biosciences, Inc.'s Q1 2025 Earnings (NYSE:RCUS) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Arcus Biosciences (NYSE:RCUS) Announces Earnings Results, Beats Estimates By $0.92 EPS wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.